The Inflation Reduction Act’s policy capping out-of-pocket costs for insulin to $35 for a month’s supply led to increases in the total number of insulin fills for Medicare beneficiaries, according to a new study from the USC Schaeffer Center for Health Policy & Economics and University of Wisconsin–Madison.
Early Invasive Breast Cancer Now Leaves Mostly Long-Term Survivors
Women diagnosed with early invasive breast cancer are now more likely to become long-term survivors, as mortality risk from the disease dropped substantially since the
June 16, 2023